Lighthouse Investment Partners LLC Buys Shares of 10,000 The Cooper Companies, Inc. (NASDAQ:COO)

Lighthouse Investment Partners LLC acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,000 shares of the medical device company's stock, valued at approximately $919,000.

Other large investors also recently bought and sold shares of the company. Byrne Asset Management LLC acquired a new position in Cooper Companies in the fourth quarter valued at $33,000. OFI Invest Asset Management acquired a new stake in shares of Cooper Companies during the fourth quarter worth about $34,000. New Age Alpha Advisors LLC acquired a new stake in shares of Cooper Companies during the fourth quarter worth about $38,000. Covestor Ltd boosted its stake in shares of Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after buying an additional 120 shares during the period. Finally, West Financial Advisors LLC acquired a new stake in shares of Cooper Companies during the fourth quarter worth about $49,000. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Stock Performance

NASDAQ COO traded up $1.47 during trading hours on Friday, hitting $82.92. 1,519,674 shares of the stock were exchanged, compared to its average volume of 1,471,543. The company has a market cap of $16.58 billion, a price-to-earnings ratio of 42.52, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08. The Cooper Companies, Inc. has a 12-month low of $69.81 and a 12-month high of $112.38. The stock has a 50-day moving average of $80.19 and a 200 day moving average of $90.10. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. The firm had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. Robert W. Baird decreased their target price on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research note on Friday, March 7th. Piper Sandler reiterated an "overweight" rating and set a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th. Stifel Nicolaus decreased their target price on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Finally, Citigroup decreased their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.